News & Articles

FEATURED ARTICLE

GDF-8 (Myostatin) antibody Apitegromab achieves success in Phase III clinical trial

On October 7, 2024, Scholar Rock announced that the Phase III clinical trial (SAPPHIRE) of Apitegromab (SRK-015) met its primary endpoint with a statistically significant and clinically...

Read more

Browse articles by topic:

Engineered T7 RNA Polymerase to Reduce dsRNA

Engineered T7 RNA Polymerase to Reduce dsRNA

May 24, 2023

1 min read

Our Chief Technology Officer, ManHee Suh, recently presented at the NextGen RNA Summit in Boston, MA his talk on "Engineered...

Read more →
Full Portfolio of In Vitro mRNA Synthesis Enzymes Submitted to FDA Drug Master Files (DMF)

Full Portfolio of In Vitro mRNA Synthesis Enzymes Submitted to FDA Drug Master Files (DMF)

April 23, 2023

2 min read

Contact us to request a quote or test sample!   Following the filings of our GMP-Grade BsaI and GMP-Grade T7...

Read more →
BsaI and T7 RNA Polymerase of KACTUS Pass FDA DMF Filing

BsaI and T7 RNA Polymerase of KACTUS Pass FDA DMF Filing

January 4, 2023

2 min read

After successful completion of DMF filings for our CRISPR Cas9 enzyme and Maxnuclease in the first half of 2022, we...

Read more →